302 related articles for article (PubMed ID: 6091153)
21. Histopathology and classification of urinary bladder carcinoma.
Friedell GH; Bell JR; Burney SW; Soto EA; Tiltman AJ
Urol Clin North Am; 1976 Feb; 3(1):53-70. PubMed ID: 936368
[No Abstract] [Full Text] [Related]
22. Multiple biopsies in bladder urothelial carcinomas. Correlation of atypical lesions with histological grade, clinical staging and number of tumors.
Escanhoela CA; Cara Ade M; Pedrini H; Azal Júnior W; Billis A
Rev Paul Med; 1992; 110(2):72-7. PubMed ID: 1340006
[TBL] [Abstract][Full Text] [Related]
23. The pathology of human bladder cancer.
Friedell GH; Parija GC; Nagy GK; Soto EA
Cancer; 1980 Apr; 45(7 Suppl):1823-31. PubMed ID: 7370933
[No Abstract] [Full Text] [Related]
24. Superficial bladder cancer: part 1. Update on etiology, classification and natural history.
Josephson DY; Pasin E; Stein JP
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1723-34. PubMed ID: 17181486
[TBL] [Abstract][Full Text] [Related]
25. Two molecular pathways to transitional cell carcinoma of the bladder.
Spruck CH; Ohneseit PF; Gonzalez-Zulueta M; Esrig D; Miyao N; Tsai YC; Lerner SP; Schmütte C; Yang AS; Cote R
Cancer Res; 1994 Feb; 54(3):784-8. PubMed ID: 8306342
[TBL] [Abstract][Full Text] [Related]
26. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
Blume B; Theuring F
Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
[TBL] [Abstract][Full Text] [Related]
27. [Radical cystectomy for superficial tumors in the BCG era].
Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
[TBL] [Abstract][Full Text] [Related]
28. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
29. [Changes in the mechanical integration of transitional epithelial cells and in the immune status of patients with bladder tumors].
Bocharova OA; Serebriakova RV; Golubeva VA; Figurin KM; Bukharkin BV; Bodrova NB; Matveev BP; Baryshnikov AIu
Urol Nefrol (Mosk); 1994; (3):27-30. PubMed ID: 8079407
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.
Cai T; Nesi G; Boddi V; Mazzoli S; Dal Canto M; Bartoletti R
Oncol Rep; 2006 Aug; 16(2):329-34. PubMed ID: 16820911
[TBL] [Abstract][Full Text] [Related]
31. Epidermal growth factor receptor, MUC-1 and MUC-2 in bladder cancer.
Cardillo MR; Castagna G; Memeo L; De Bernardinis E; Di Silverio F
J Exp Clin Cancer Res; 2000 Jun; 19(2):225-33. PubMed ID: 10965823
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis, staging, and classification of bladder tumors.
Cummings KB
Semin Urol; 1983 Feb; 1(1):7-14. PubMed ID: 6679097
[No Abstract] [Full Text] [Related]
33. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors.
Palou J; Rodríguez-Rubio F; Millán F; Algaba F; Rodríguez-Faba O; Huguet J; Villavicencio H
Urology; 2009 Jun; 73(6):1313-7. PubMed ID: 19362341
[TBL] [Abstract][Full Text] [Related]
34. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
Lamm DL; Blumenstein BA; Crissman JD; Montie JE; Gottesman JE; Lowe BA; Sarosdy MF; Bohl RD; Grossman HB; Beck TM; Leimert JT; Crawford ED
J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
[TBL] [Abstract][Full Text] [Related]
35. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
Möllhoff S; Rathert P
Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
[No Abstract] [Full Text] [Related]
36. Pathology and staging of urothelial tumors of the kidney and ureter.
Melamed MR; Reuter VE
Urol Clin North Am; 1993 May; 20(2):333-47. PubMed ID: 8388136
[TBL] [Abstract][Full Text] [Related]
37. [Histomorphological variants of carcinoma in situ of the urinary bladder].
Blume B; Theuring F
Zentralbl Allg Pathol; 1984; 129(3):195-9. PubMed ID: 6091364
[TBL] [Abstract][Full Text] [Related]
38. Epithelial abnormalities of urinary bladder.
Mostofi FK; Davis CJ
Prog Clin Biol Res; 1984; 162A():81-93. PubMed ID: 6483921
[TBL] [Abstract][Full Text] [Related]
39. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
40. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
